HealthDay - Two Drugs for Heart Failure Show Mixed Results
Two new studies have produced mixed results for two different drugs that are often used to treat heart failure.
In the first study, researchers found limited benefit from a drug called valsartan (Diovan), which is used to lower systolic blood pressure. The second study found no benefit from the use of a drug known as nesiritide (Natrecor) for heart failure in an outpatient setting. Both reports are published in the May 21 issue of Circulation: Heart Failure .
“When you get heart failure, which means that the heart’s function is not normal, and the pumping function of the heart deteriorates, low blood pressure becomes a risk factor,” said Dr. Inder S. Anand, from the cardiology department at the VA Medical Center in Minneapolis, and author of the first study.
Related Results
Novartis claims R$1.1mil profit for 2003.
Diovan(R) (Valsartan) the First Blood Pressure Medication in a Large-Scale Cl…
Novartis lures consumers with value-based program
Novartis’ sales on track in third quarter; profits rise 7% as Diovan, Gleevec…
New hope for soccer ace’s dad
All drugs used to treat heart failure are also drugs that are used to lower blood pressure, Anand said. “So when …
Read the full article with a Free Trial at MyWire.
